Walgreens Boots Alliance (NASDAQ:WBA) Has No Shortage Of Debt
Feb 13
Have your own idea? Try our Stock Screener
U.S. Drug Retail Industry Analysis
UpdatedFeb 21, 2025
DataAggregated Company Financials
Companies11
- 7D6.7%
- 3M15.8%
- 1Y-51.2%
- YTDn/a
In the last week, the Drug Retail industry is up 15%, with Walgreens Boots Alliance up 14%. In the past year, the industry is down 50%. As for the next few years, earnings are expected to grow by 88% per annum.
Industry Valuation and Performance
Has the U.S. Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 21 Feb 2025 | US$10.8b | US$153.8b | -US$8,983,689,817.14 | n/a | -1.2x | 0.07x |
| Sun, 19 Jan 2025 | US$12.2b | US$153.8b | -US$8,983,361,380.12 | n/a | -1.4x | 0.08x |
| Tue, 17 Dec 2024 | US$10.6b | US$151.0b | -US$8,784,207,579.33 | n/a | -1.2x | 0.07x |
| Thu, 14 Nov 2024 | US$9.3b | US$151.0b | -US$8,682,985,118.51 | 88.6x | -1.1x | 0.06x |
| Sat, 12 Oct 2024 | US$9.0b | US$148.9b | -US$5,859,014,737.50 | 76.1x | -1.5x | 0.06x |
| Mon, 09 Sep 2024 | US$7.7b | US$147.8b | -US$5,892,537,482.29 | n/a | -1.3x | 0.05x |
| Wed, 07 Aug 2024 | US$9.4b | US$147.8b | -US$5,889,114,291.53 | n/a | -1.6x | 0.06x |
| Fri, 05 Jul 2024 | US$9.7b | US$147.8b | -US$5,905,477,443.71 | n/a | -1.6x | 0.07x |
| Sun, 02 Jun 2024 | US$14.2b | US$146.9b | -US$6,130,762,262.14 | 38.5x | -2.3x | 0.1x |
| Tue, 30 Apr 2024 | US$15.4b | US$146.9b | -US$6,142,390,888.62 | 38.5x | -2.5x | 0.1x |
| Thu, 28 Mar 2024 | US$18.3b | US$144.7b | US$486.0m | 31.6x | 37.6x | 0.1x |
| Sat, 24 Feb 2024 | US$18.9b | US$144.7b | US$499.5m | 32.6x | 37.9x | 0.1x |
| Mon, 22 Jan 2024 | US$19.2b | US$144.7b | US$444.9m | 36.7x | 43.1x | 0.1x |
| Wed, 20 Dec 2023 | US$22.7b | US$141.4b | -US$3,209,371,424.00 | 46.2x | -7.1x | 0.2x |
| Fri, 17 Nov 2023 | US$18.2b | US$164.8b | -US$4,844,386,334.00 | 54.1x | -3.8x | 0.1x |
| Sun, 15 Oct 2023 | US$20.4b | US$141.3b | -US$3,213,527,036.00 | 361.3x | -6.3x | 0.1x |
| Tue, 12 Sep 2023 | US$18.9b | US$138.4b | -US$3,448,621,234.00 | 361.3x | -5.5x | 0.1x |
| Thu, 10 Aug 2023 | US$25.7b | US$138.3b | -US$3,450,612,990.00 | 361.3x | -7.4x | 0.2x |
| Sat, 08 Jul 2023 | US$25.5b | US$138.3b | -US$3,448,697,886.00 | n/a | -7.4x | 0.2x |
| Mon, 05 Jun 2023 | US$27.2b | US$135.5b | -US$3,272,071,933.00 | n/a | -8.3x | 0.2x |
| Wed, 03 May 2023 | US$29.2b | US$135.5b | -US$3,266,606,474.00 | n/a | -8.9x | 0.2x |
| Fri, 31 Mar 2023 | US$30.2b | US$135.5b | -US$3,258,190,213.00 | n/a | -9.3x | 0.2x |
| Sun, 26 Feb 2023 | US$31.2b | US$134.2b | -US$3,075,848,759.00 | n/a | -10.1x | 0.2x |
| Tue, 24 Jan 2023 | US$31.9b | US$134.3b | -US$3,077,373,039.00 | n/a | -10.4x | 0.2x |
| Thu, 22 Dec 2022 | US$33.6b | US$134.7b | US$4.2b | 7.7x | 7.9x | 0.2x |
| Sat, 19 Nov 2022 | US$34.7b | US$134.7b | US$4.2b | 7.9x | 8.2x | 0.3x |
| Mon, 17 Oct 2022 | US$29.0b | US$134.7b | US$4.2b | 6.6x | 6.9x | 0.2x |
| Wed, 14 Sep 2022 | US$32.0b | US$136.6b | US$5.0b | 6.2x | 6.4x | 0.2x |
| Fri, 12 Aug 2022 | US$34.9b | US$136.6b | US$5.0b | 6.8x | 7x | 0.3x |
| Sun, 10 Jul 2022 | US$32.8b | US$136.6b | US$5.0b | 6.3x | 6.6x | 0.2x |
| Tue, 07 Jun 2022 | US$37.7b | US$138.0b | US$5.8b | 6.3x | 6.5x | 0.3x |
| Thu, 05 May 2022 | US$37.4b | US$138.0b | US$5.8b | 48.1x | 6.5x | 0.3x |
| Sat, 02 Apr 2022 | US$38.6b | US$162.5b | US$5.3b | 6.7x | 7.2x | 0.2x |
| Mon, 28 Feb 2022 | US$40.7b | US$161.4b | US$5.6b | 6.7x | 7.2x | 0.3x |
Price to Earnings Ratio
7.2x
Current Industry PE
- Investors are pessimistic on the American Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.17x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does U.S. Drug Retail compare with similar industries?
| US Market | -0.41% | |
| Consumer Staples | -2.29% | |
| Food and Staples Retail | -5.16% | |
| Drug Retail | 6.69% | |
| Food Distributors | -0.66% | |
| Food Retail | -2.00% | |
| Big Box Super Stores | -5.70% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance | US$10.51 | 7.8% +US$656.8m | -51.3% | PS0.06x | |
| YI 111 | US$8.20 | 11.6% +US$7.3m | -39.3% | PS0.03x | |
| MGRX Mangoceuticals | US$4.72 | 6.5% +US$742.8k | 49.3% | PS16x | |
| CJJD China Jo-Jo Drugstores | US$1.35 | 0.4% +US$30.9k | -67.8% | PS0.06x |